Clinical Trials Browser

Phase 2 × Pediatric Solid Tumors × Other solid neoplasm × Clear all

NCT02747537 2019-09-09

Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors With Sorafenib in Combination With Irinotecan

Phase 2 Withdrawn

Other solid neoplasm

Pediatric Solid Tumors